Venus Medtech (Hangzhou) Inc.
HKEX:2500.HK
5.62 (HKD) • At close July 23, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Assets: | |||||||
| Current Assets: | |||||||
| Cash & Cash Equivalents
| 774.396 | 1,879.431 | 2,955.212 | 2,708.17 | 2,413.254 | 164.914 | 59.015 |
| Short Term Investments
| 7.24 | 0 | -4.313 | 44.128 | 0 | 0 | 13.068 |
| Cash and Short Term Investments
| 781.636 | 1,879.431 | 2,955.212 | 2,752.298 | 2,413.254 | 164.914 | 72.083 |
| Net Receivables
| 290.607 | 303.388 | 302.096 | 231.031 | 162.2 | 0 | 0 |
| Inventory
| 112.942 | 104.396 | 90.519 | 59.904 | 24.789 | 16.685 | 9.418 |
| Other Current Assets
| 405.76 | 181.755 | 91.795 | 361.328 | 304.208 | 109.039 | 40.183 |
| Total Current Assets
| 1,608.067 | 2,468.97 | 3,439.622 | 3,360.433 | 2,904.451 | 290.638 | 121.684 |
| Non-Current Assets: | |||||||
| Property, Plant & Equipment, Net
| 700.292 | 472.023 | 261.546 | 109.611 | 61.115 | 48.081 | 19.896 |
| Goodwill
| 1,024.354 | 1,238.535 | 519.711 | 487.317 | 479.626 | 471.857 | 0 |
| Intangible Assets
| 551.153 | 612.304 | 306.595 | 248.371 | 189.904 | 191.12 | 23.726 |
| Goodwill and Intangible Assets
| 1,575.507 | 1,850.839 | 826.306 | 735.688 | 669.53 | 662.977 | 23.726 |
| Long Term Investments
| 509.996 | 477.08 | 573.846 | 64.865 | 29.74 | 0 | 15.029 |
| Tax Assets
| 17.66 | 9.941 | 8.17 | 1.156 | 2.8 | 2.711 | 0 |
| Other Non-Current Assets
| 2.192 | 3.982 | -0.033 | 46.474 | 1.172 | 29.974 | 13.676 |
| Total Non-Current Assets
| 2,805.647 | 2,813.865 | 1,669.835 | 957.794 | 764.357 | 743.743 | 72.327 |
| Total Assets
| 4,413.714 | 5,282.835 | 5,109.457 | 4,318.227 | 3,668.808 | 1,034.381 | 194.011 |
| Liabilities & Equity: | |||||||
| Current Liabilities: | |||||||
| Account Payables
| 33.855 | 9.126 | 8.751 | 5.295 | 1.452 | 0.983 | 2.94 |
| Short Term Debt
| 494.7 | 246.06 | 22.627 | 11.092 | 128.992 | 85.959 | 32.164 |
| Tax Payables
| 2.157 | 5.006 | 0.48 | 0 | 1.939 | 5.859 | 1.849 |
| Deferred Revenue
| -37.722 | 0 | 163.05 | 374.975 | 425.652 | 403.708 | 60.715 |
| Other Current Liabilities
| 314.335 | 236.918 | 14.106 | 14.155 | 12.362 | 5.48 | 0.148 |
| Total Current Liabilities
| 805.168 | 492.104 | 208.534 | 405.517 | 568.458 | 496.13 | 95.967 |
| Non-Current Liabilities: | |||||||
| Long Term Debt
| 331.486 | 653.583 | 48.148 | 21.671 | 17.312 | 15.355 | 3.923 |
| Deferred Revenue Non-Current
| 1.63 | 0.6 | 0 | 1.062 | -37.292 | 13.796 | 12.923 |
| Deferred Tax Liabilities Non-Current
| 17.776 | 17.411 | 53.451 | 32.942 | 37.292 | 38.726 | -11.94 |
| Other Non-Current Liabilities
| 338.308 | 487.826 | 167.48 | 0 | 37.292 | 0 | 11.94 |
| Total Non-Current Liabilities
| 689.2 | 1,159.42 | 269.079 | 55.675 | 54.604 | 67.877 | 16.846 |
| Total Liabilities
| 1,494.368 | 1,651.524 | 477.613 | 461.192 | 623.062 | 564.007 | 112.813 |
| Equity: | |||||||
| Preferred Stock
| 2,898.934 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 441.012 | 441.012 | 441.012 | 422.969 | 404.469 | 300 | 0 |
| Retained Earnings
| -2,881.812 | -2,178.058 | -1,120.359 | -746.723 | -564.734 | 0 | 0 |
| Accumulated Other Comprehensive Income/Loss
| 2,462.514 | 305.182 | 185.249 | 200.191 | 274.061 | -12.519 | -7.897 |
| Other Total Stockholders Equity
| 0 | 5,039.728 | 5,039.728 | 3,938.987 | 2,923.182 | 174.083 | 80.188 |
| Total Shareholders Equity
| 2,920.648 | 3,607.864 | 4,545.63 | 3,815.424 | 3,036.978 | 461.564 | 72.291 |
| Total Equity
| 2,919.346 | 3,631.311 | 4,631.844 | 3,857.035 | 3,045.746 | 470.374 | 72.291 |
| Total Liabilities & Shareholders Equity
| 4,413.714 | 5,282.835 | 5,109.457 | 4,318.227 | 3,668.808 | 1,034.381 | 194.011 |